Murine bone marrow Lin-, Ly6A/E + cells have been fractionated on the basis of rhodamine123 retention into Rh123 m~d/hi and Rh123 l~ subpopulations. These populations have different responses to hemopoietic growth factors with respect to in vitro colony formation. Cells from either fraction were not stimulated by only granulocyte-colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), interleukins 1 and 6 (IL-1 and -6), or leukemia inhibitory factor (LIF) alone. The Rh123 m~a/hi, but not the Rh1231~ fraction, contained calls that could be stimulated by either stem cell factor (SCF) or IL-3 alone. When combinations of growth factors were added, the Rh123 m~d/hi fraction produced more colonies, and responded to a wider range of factor combinations than the Rh123 l~ population. When tested in vivo, both populations contained no detectable day 8 colony-forming unit-spleen (CFU-S), and similar frequencies of day 13 CFU-S. When transplanted into lethally irradiated recipients (100 cells/recipient), significant numbers of donor ceils (67-73%) were found in the peripheral blood of Rh123 l~ recipients. Both myeloid and lymphoid cells were of donor origin. By comparison, the Rh123 reed/hi population produced recipients with 1-2% donor cells in peripheral blood, the majority of which were lymphoid.
T
he publication by Spangrude et al. (1) of a method for enriching murine bone marrow cells on the basis of low levels of Thy-1 expression (Thy-ll~ absence of expression of a panel of antigens defining mature hemopoietic lineages (Lin-), and expression of Sca-1 (the Sca-1 antigen, also known as Ly6A/E), has generated considerable discussion concerning the degree of purity and identity of pluripotential hemopoietic stem cells (PHSC) 1 (1) (2) (3) (4) (5) (6) (7) (8) . Ceils with the Thy-1 l~ Lin-, Ly6A/E + phenotype were significantly enriched for CFU-S(dl2) (cells capable of forming spleen colonies 12 d after transplantation of lethally irradiated recipients), the implication being that some of the CFU-spleen (S) were in fact PHSC and could therefore reconstitute the hemopoietic system of lethally irradiated recipients (1) . Support for this concept was difficult to assess as the results from only one animal grafted with Thy-1 l~ Lin-, Ly6A/E + cells, 6 wk previously, were shown (1) . The Thy-1 l~ Lin-, Ly6A/E + population has subsequently been tested at limiting cell numbers (down to one cell) for long-term repopulating ability, but only 1 of 40 to 1 of 13 cells generated detectable blood cells in vivo for periods of up to 3-7 wk, with very few cells producing progeny for much longer (9) . Only 1 of 280 mice transplanted 1 Abbreviations used in this ~per: CFC, colony-forming cell; CFU-S, CFUspleen; HPP, high proliferative potential; LIF, leukemia inhibitory factor; PHSC, pluripotential hemopoietic stem cell; SCF, stem cell factor. was able to supply sufficient cells, of donor origin, for secondary transplantation (9) . The Thy-11~ Lin-, Ly6A/E + fraction has been further subdivided on the basis of rhodamine123 retention (10) . When compared with the Rh123 hi subset, it was shown that the Rh123 l~ cells had a lower frequency of CFU-Sd13, a greater ability to reconstitute spleen and bone marrow 13 d after transplantation, and that these Rh123 I~ subset-derived marrow cells were able to produce donor cells in the peripheral blood of secondary recipients for periods of at least 8 wk (10) . Finally, when the thymus of secondary recipients was examined, donor cells were detected in both myeloid and lymphoid populations, the conclusion being that Rh123 l~ Thy-11~ Lin-, Ly6A/E + cells were multipotential (10) , albeit the data obtained was from examination of only the thymus, a tissue not normally assayed for mutipotential cells. When assayed in vitro, with limited combinations of growth factors, a similar frequency of cells with colony-forming ability was observed with both Rh123 subsets (10) .
We have divided Lin-, Ly6A/E § cells into Rh1231~ and Rh123 med/hi fractions, and show that these have different responses to hemopoietic growth factors with respect to in vitro colony formation. In addition, a minimum of 1 in 40 cells of the Rh123 l~ population was able to engraft lethally irradiated recipients, producing both myeloid and lymphoid cells for at least 19 wk. In contrast, cells of the Rh123 m~/hi frac-tion, after engraftment, predominantly repopulated the lymphoid lineages.
Materials and Methods

Animals.
Mice were used at 6-12 wk of age, and were of the following strains: C57BL/Ka-Thy-l.1 (Thy-l. 1 (10-12 animals) were killed by cervical dislocation, and the cells from both femurs and tibiae were flushed out using a 2.5-ml syringe with a 21-gauge needle. After washing, the bone marrow cells were resuspended in 10 ml balanced salt solution containing 5% BSS.FCS and 0.1/zg/ml rhodamine123 (Eastman Kodak Co., Rochester, NY), and incubated at 37~ for 30 min. After washing once, the cells were resuspended in 10 ml flesh BSS.FCS, and incubated at 37~ for another 30 min. The cell suspension was then diluted further by the addition of 10 ml of BSS.FCS, and layered on top of Ficoll (Pharmacia Inc., Piscataway, NJ), and centrifuged at 1,600 g for 10 min at room temperature. Light density viable bone marrow cells were recovered at the interphase and washed with 10 ml of BSS.FCS. After washing and resuspension in 3 ml of BSS.FCS, the cells were incubated on ice for 15 min with a mixture of rat mAbs, GK1.5, 53-6.72, 53-7.3.13, RA3-6B2, M1/70.15.11.5, and RB6-8C5, reactive with specific antigens on mature T, B, and myeloid cells (neutrophils and monocytes/macrophages). After washing with 10 ml BSS.FCS and centrifugation through an FCS underlayer, the cells were resuspended in 1 ml of BSS.FCS and mixed together with 1 ml of pre-washed magnetic Dynalbeads (Dynalbeads M450; Dynal Inc., Oslo, Norway), and incubated for 20 min at 4~ with constant mixing. After diluting the mixture by adding 5 ml of flesh BSS.FCS, the beads, together with the cells bound to them, were removed magnetically. The procedure was repeated twice to both bead and bead-flee cell populations. The bead-flee cell fractions were pooled, centrifuged, and were then stained sequentially for 15 min each in 0.5 ml vol on ice with PE-conjugated goat anti-rat Ig (mouse absorbed), biotinylated E13 161.7 mAb and Texas red-avidin. Each staining step was followed by a washing step with 10 ml of BSS.FCS, and the bone marrow cells were pre-incubated with 50/zg normal rat Ig for 2-3 min before the addition of biotinylated E13 161.7 Ab. After the final wash, the cells were resuspended in 3 ml of BSS.FCS containing 10/zg/ml pmpidium iodide (Calbiochem Corp., La Jolla, CA), and filtered through a 63-#m pore size nylon screen. FACS | was performed using an unmodified FACStar-Plus | instrument (Becton Dickinson Immunocytometry Systems, San Jose, CA). All cells were kept at 4~ throughout the whole procedure. After completion of cell sorting, the deflected cells were centrifuged at 1,500 rpm for 5 min, resuspended, and counted using a hemocytometer.
In Vitro Cultures. Marrow Lin-, Ly6A/E + cells flactionated into Rh1231~ or tLh123 m.a/h~ subpopulations as indicated in Fig. 1 (bottom), were cultured at 100-200 cells/culture in duplicate 35-ram petri dishes. The cells were immobilized in 1 ml of agar medium and stimulated by various combinations of the following stimuli at 1,000 U/ml unless specified otherwise: murine II.-3, GM-CSF, M-CSF, or human G-CSF, prepared in this laboratory and kindly provided by Dr. N. A. Nicola. Human IL-6 (kindly provided by Sandoz, Basel, Switzerland) and rat SCF (kindly provided by Dr. Zsebo, Amgen, Thousand Oaks, CA) were used at 0.5/zg/ml and 200 ng/ml, respectively. Recombinant human ID1 (kindly provided by Dr. A. Gearing, Oxford University, Oxford, UK) was used at 100 U/ml. Colonies of >50 cells were scored at day 12 of incubation. The cell types within colonies were determined in situ after fixation of cultures with 2.5% glutaraldehyde, air-drying, and staining for acetylcholinesterase and with hematoxylin and Luxol Fast blue.
Transplantation. Recipient animals, C57BL/6-Ly-5.1-Pep ~ (Ly5.1) were exposed to 11.0 Gy of 7 radiation from a 137Cs source (Atomic Energy, Ottawa, Canada) at a dose rate of 31cGy/min. The 11.0-Gy dose was delivered in two equal exposures, given 3 h apart. Irradiated recipients were transplanted intravenously with indicated numbers of Rh123 ~, Lin-, Ly6A/E +, or Rh123 m~, Lin-, Ly6A/ E + cells in the absence of any filler cells. Animals were maintained on aqueous antibiotics (neomycin sulphate, 1.1 grams/liter for at least 3 wk after transplantation. Hemopoietic reconstitution was determined by the percentage of donor-derived (LyS.2 +) nucleated cells in the peripheral blood of recipient (LyS. 1) animals using Ly5.2 allelic-specific mAb, $450-15.2 (kindly provided by Dr. I. Mackenzie, University of Melbourne, Victoria, Australia), together with rat mAbs, RA3-6B2 (for B cells) and Gkl.5 and 53-6.72 (for T lymphocytes). Forward and perpendicular light scatter were used to define granulocytes and monocytes/macrophages, and this was confirmed by using the myelomonocytic-specific rat mAbs, RB6-8C5 and M1/70.
Resu|ts
Isolation of Rhl23 Subsets of Ly6A/E +, Lin-Cells. We have isolated routine Lin-, Ly6A/E + cells as these have been shown to be phenotypically and functionally similar to Thy-1 l~ Lin-, Ly6A/E + cells (11) . Although the Lin-, Ly6A/E + population contained only 30-50% Thy-11~ cells and a twofold-lower frequency of day 13 CFU-S, their ability to confer long-term in vivo hemopoietic engraftment was not significantly impaired compared with the homogenous Thy-11~ Lin-, Ly-6A/E + cells (11) . We have further subfractionated the Lin-, Ly-6A/E + marrow population using the fluorescent dye, rhodamine123. Fig. 1 (top) shows the distribution of Ly6A/E +, Lin-cells with reference to their Rh123 fluorescence intensity. The Ly6A/E + , Lin-population can be divided into two recognizable populations, namely Rh123 l~ and Rh123 =~d/hi, based on relative forward light scatter characteristics (Fig. 1, bottom) . When compared with a standard reference cell population, lymph node cells, which had a mean forward light scatter at channel 109, the Rh123 L' population had a mean forward light scatter at channel number 118, and the P, h123 mea/h~ population had one at 130. Morphologically, the majority of the Rh1231~ cells were small mononuclear cells with a chromatin pattern resembling that of small lymphocytes, whereas those of the Rh123 med/hi population were medium-sized blasts.
In Vitro Colony Formation. To evaluate the in vitro colonyforming cell (CFC) content of these populations, cells (150 cells/culture) from each population were cultured in semisolid agar medium stimulated with recombinant cytokines used either alone, or in various combinations. Colony formation did not occur, with either fraction, when cultures contained only G-, GM-, M-CSF, IL-1, -6, or leukemia inhibitory factor (Fig. 2) . The Rh123 m=v~, but not the Rh1231~ population, contained cells that could be stimulated by either SCF or II.-3 alone (Fig. 2) . When two cytokines were added simultaneously to the cultures, SCF, II.-3, IL-6, and G-CSF, markedly synergized with one another and stimulated colony formation by both populations. However, the Rh123 m*d/~ population consistently produced more colonies (up to 30 per 150 cells), and was responsive to a wider range of cytokine combinations than the Rh123 l~ cells. A similar cloning efficiency of 30-50% for both populations was observed when all seven of the growth factors tested were added simultaneously to cultures. Morphological analysis of these macroscopic colonies, stimulated by the addition of seven factors, showed no significant difference between the two Rh123 populations. The majority of colonies consisted of neutrophils and macrophages, but some (10-20%) mixed colonies (containing eosinophils and/or megakaryocytes) were also observed. As most of the colonies were macroscopic in size and required multiple cytokines for their optimal growth, these can be classified as being derived from high proliferative potential CFCs (HPP-CFC) (12) .
In Vivo Repopulation. To evaluate functional ability in vivo, 100 cells from each Rh123 population were transplanted into lethally irradiated congenic Ly-5.1 recipients. Both the Rh123 l~ and Rh123 m~m populations contained no detectable day 8 CFU-S and had a similar frequency of day 13 CFU-S (Table 1) . In other experiments, the Kh123 I~ cells produced about twofold-less day 13 spleen colonies than the Kh hi ceils (data not shown). Both populations conferred a similar level of radioprotection to the lethally irradiated recipients (Table  1) . However, when the surviving recipients were examined at both 8 and 19 wk after transplantation, significant levels of donor-derived (LyS.2) peripheral blood nucleated cells were found only in mice receiving Rh123 i~ Lin-, Ly-6A/E + cells, a median (_+ SE)of 67.5 __ 5.7% and 72.7 _+ 8.6, at 8 and 19 wk respectively, compared with 2.2 _+ 1.7% and 0.8 +_ 0.6% in mice transplanted with Kh123 m-a/hi, Lin-, Ly-6A/E + cells. Furthermore, whereas donor-derived nucleated blood cells were of both lymphoid and myeloid lineages in recipients transplanted with 100 Rh123 l~ Lin-, Ly-6A/E + cells (Fig. 3) , donor-derived circulating myeloid cells were absent in recipients transplanted with R.h123 m~/hi, Lin-, Ly6A/E + cells (Fig. 3) . Even in recipients transplanted with 1,500 ILh123 m'a/hs cells, although displaying an increased level (a median of 12.0 _+ 1.9% measured 17 wk posttransplantation) of donor-derived nucleated peripheral blood cells, the majority of these were lymphoid (B and T) cells (Fig. 3) . Only one of four recipients examined, showed the presence of about 8% donor cells in the circulating myeloid population (Fig. 3) .
Discussion
The Thy-1 ]~ Lin-, LY6A/E + cell population has been fractionated on the basis of rhodamine123 retention (10) . It was concluded, albeit on a limited number of assays, that there was no difference between the Rh123 l~ and Rh123 hi subsets with regard to in vitro CFC numbers (10) . A similar result has also been reported recently, although once again using only a limited number of growth factor combinations (13) . However, it was also shown that the ILh123 ~~ population was capable of a 13-d marrow repopulation, and that these marrow cells contained sufficient donor cell reserves to repopulate secondary lethally irradiated recipients for up to 8 wk, although multilineage development was only tested for and demonstrated in the thymus (10) . These results suggested that the Rah123 I~ population was less mature than the Rh123 hi fraction, but because the cells had been passaged through primary recipients for 13 d before secondary transplantation, it was not possible to determine the direct repopulating ability of the Rh123 l~ cells, or the frequency of such cells. Although the experiments were incomplete, it was suggested that the differences observed in vivo may have been due to localization in differing microenvironments, rather than to inherent differences between the Rh123 subsets (8) .
The results presented here, demonstrate that the two Rh123 fractions are functionally different. The in vitro results demonstrate that in the same environment, there is a differential responsiveness to individual and combinations of growth factors. The in vivo results also demonstrate that there are functional differences between the two Rh123 subpopulations. The Rh123 l~ population repopulated both myeloid and lymphoid lineages, whereas the Rh123 m~/hi population predominantly engrafted the lymphoid lineages. Taken together, these in vitro and in vivo results suggest that there is genuine intrinsic heterogeneity within the cells of the Lin-, Ly6A/E + phenotype that accounts for the differing behavior in vitro and after engraftment in vivo.
